Abstract

A total of 21 833 inhibitors of the central nervous system (CNS) were collected from Binding-database and analyzed using discriminant analysis (DA) techniques. A combination of genetic algorithm and quadratic discriminant analysis (GA-QDA) was proposed as a tool for the classification of molecules based on their therapeutic targets and activities. The results indicated that the one-against-one (OAO) QDA classifiers correctly separate the molecules based on their therapeutic targets and are comparable with support vector machines. These classifiers help in charting the chemical space of the CNS inhibitors and finding specific subspaces occupied by particular classes of molecules. As a next step, the classification models were used as virtual filters for screening of random subsets of PUBCHEM and ZINC databases. The calculated enrichment factors together with the area under curve values of receiver operating characteristic curves showed that these classifiers are good candidates to speed up the early stages of drug discovery projects. The "relative distances" of the center of active classes of biosimilar molecules calculated by OAO classifiers were used as indices for sorting the compound databases. The results revealed that, the multiclass classification models in this work circumvent the definition inactive sets for virtual screening and are useful for compound retrieval analysis in Chemoinformatics.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.